The Initial Trial Phase is the experimental phase where mHealth solutions are tested in large-scale nationwide deployments, typically in pilot studies. The focus is on feasibility, technology testing, and understanding user interactions and outcomes.

Which one of these Digital Helth Technologies has had the most clinical impact?

What is an identified barrier to mHealth growth in the commercialization phase?

The cardiologist guest speaker explained a very small implantable device. Besides the fact that this device was very small and communicated wirelessly, what was so unique about this device?

Which feature is typical of second-generation mHealth applications?

When it comes to advantages and disadvantages of self-tracking health data, we learned that too much information can be overwhelming and counterproductive if not analyzed and used correctly. This occurance is also called [blank1]. Hint: The answer is two words. 

What does MFA stand for? It stand for  .

mHealth applications will not integrate into doctors’ treatment plans until the commercialization phase.

Self-tracking health data can delay identifying health issues since the data is not as accurate and reliable as the provider-owned data in mHealth apps.

HIPAA requires you to have the electronic data encrypted. We talked about two types of encryption. One was encryption at rest. What do you call the second type of encryption? (Worth 1 point) Give an example of this second type of encryption. (Worth an additional 1 point)